Showing results (731-740 of 1,680) with videos related to

Sort By:
Pageof 168
Physical Chemistry Chemical Physics : PCCP|January 14, 2026
Electronic transport in antiaromatic moleculesKenan Uriostegui, Jorge A Lizarraga, Fernando Martínez-Villarino, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 24, 2025
Virtual Screening of FDA-Approved Drugs on Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) to Obtain New Trypanocidal AgentsAlfredo Juarez-Saldivar, Lenci K Vazquez-Jimenez, Eyra Ortíz-Pérez, et al.
International Journal of Sports Medicine|May 21, 2021
Swimming with Swimsuit and Wetsuit at Typical vs. Cold-water Temperatures (26 vs. 18 ℃)Ana Gay, Rodrigo Zacca, J Arturo Abraldes, et al.
The International Journal of Periodontics & Restorative Dentistry|May 8, 2024
Immediate Implant Placement in the Esthetic Area Using an Inverted Body-Shift Design: A Prospective Clinical Pilot StudyAndrea Galve-Huertas, Erika Brancacci, Susana García-González, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 31, 2005
Oral protein-energy supplements in peritoneal dialysis: a multicenter studyJosep Teixidó-Planas, Alberto Ortiz, Francisco Coronel, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCRA Solari, S Ortíz, A Soto, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|March 14, 2021
Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from MexicoAdrián Martínez-Meléndez, Rayo Morfin-Otero, Licet Villarreal-Treviño, et al.
Actas Urologicas Espanolas|March 20, 2022
Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT studyR Martins de Almeida, L Mateu Arrom, A Ortíz Núñez, et al.
Ginecologia Y Obstetricia De Mexico|May 18, 1999
[Catheterization of the tubal ostium using hysteroscopy under laparoscopic guidance]C Salazar López-Ortíz, H L Mondragón Alcocer, L Hernández Vivar, et al.
Clinical and Experimental Immunology|August 1, 1995
Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritisA Ortíz, J Alonso, M Gómez-Chiarri, et al.
Pageof 168